ConductScience.org, home

Paper39208374

A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease.

Mahal BA and 8 others. JCO Precis Oncol, 2024. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease. Papers, record 39208374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39208374

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease.
PubMed
Journal
JCO Precis Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.77, provisional
iCite
Revised in PubMed
2026-07-04
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Early Detection of CancerMajor topic
Neoplasm GradingMajor topic
Prostatic NeoplasmsMajor topic
Aged
Humans
Male
Middle Aged
DNA Methylation
Overdiagnosis
Prospective Studies

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02889978The Circulating Cell-free Genome Atlas StudyDerived from the trialYesClinicalTrials.gov
NCT04241796Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical PracticeDerived from the trialYesClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in39413340Erratum: A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease.https://conductscience.org/library/papers/39413340PubMed
Comment in39298695Progress and Promise for Multicancer Early Detection Testing in Prostate Cancer.https://conductscience.org/library/papers/39298695PubMed

Download CSV of comments and corrections

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132554709ctDNA monitoring using patient-specific sequencing and integration of variant reads.Sci Transl Med2020https://conductscience.org/library/papers/32554709PubMed
235948080Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.Am J Pathol2022https://conductscience.org/library/papers/35948080PubMed
324439788Overdiagnosis and overtreatment of prostate cancer.Eur Urol2014https://conductscience.org/library/papers/24439788PubMed
434432811Clinical correlates of circulating cell-free DNA tumor fraction.PLoS One2021https://conductscience.org/library/papers/34432811PubMed
537805216Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.Lancet2023https://conductscience.org/library/papers/37805216PubMed
638201510A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns.Cancers (Basel)2023https://conductscience.org/library/papers/38201510PubMed
714519749Comparing survival of a sample to that of a standard population.J Natl Cancer Inst2003https://conductscience.org/library/papers/14519749PubMed
831142840Genome-wide cell-free DNA fragmentation in patients with cancer.Nature2019https://conductscience.org/library/papers/31142840PubMed
933506766Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.Ann Oncol2020https://conductscience.org/library/papers/33506766PubMed
1024553385Detection of circulating tumor DNA in early- and late-stage human malignancies.Sci Transl Med2014https://conductscience.org/library/papers/24553385PubMed
1131528835Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer.JCO Precis Oncol2019https://conductscience.org/library/papers/31528835PubMed
1237255363Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.Cancer Epidemiol Biomarkers Prev2023https://conductscience.org/library/papers/37255363PubMed
1337927174The enigma of race and prostate cancer.Cancer2024https://conductscience.org/library/papers/37927174PubMed
1434426664Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.Br J Cancer2021https://conductscience.org/library/papers/34426664PubMed
1534176681Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.Ann Oncol2021https://conductscience.org/library/papers/34176681PubMed
1633658587Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.Sci Rep2021https://conductscience.org/library/papers/33658587PubMed
1729348365Detection and localization of surgically resectable cancers with a multi-analyte blood test.Science2018https://conductscience.org/library/papers/29348365PubMed
1838424555Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK.BMC Med2024https://conductscience.org/library/papers/38424555PubMed
1938378299Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.Eur Urol2024https://conductscience.org/library/papers/38378299PubMed
2036400018Evaluation of cell-free DNA approaches for multi-cancer early detection.Cancer Cell2022https://conductscience.org/library/papers/36400018PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42388617Early detection of multiple cancers: the era of methylation-based liquid biopsy.Front Oncol2026https://conductscience.org/library/papers/42388617PubMed
41818645Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis.JCO Precis Oncol2026https://conductscience.org/library/papers/41818645PubMed
41480180Liquid biopsy in genitourinary cancers: Diagnostic and prognostic implications.World J Clin Oncol2025https://conductscience.org/library/papers/41480180PubMed
40979549Emerging tools for the early detection of prostate cancer.BJUI Compass2025https://conductscience.org/library/papers/40979549PubMed
40863429The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology.J Pers Med2025https://conductscience.org/library/papers/40863429PubMed
40749671Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications.Cancer Cell2025https://conductscience.org/library/papers/40749671PubMed
40323021Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early Detection.Cancer Res Commun2025https://conductscience.org/library/papers/40323021PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39208374

GET https://conductscience.org/api/papers/v1/39208374/authors